Developing nanobodies for COVID-19 treatment and prevention
Structure-guided and epitope-based design of potent and broadly neutralizing nanobodies for COVID-19 mucosal immunotherapy
This study is working on new treatments for COVID-19 that use tiny proteins called nanobodies to target parts of the virus, aiming to help people stay protected and feel better even if the virus changes over time.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Massachusetts Med Sch Worcester NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project ID | NIH-10676090 on NIH RePORTER |
What this research studies
This research focuses on creating effective nanobodies that can target specific parts of the SARS-CoV-2 virus to improve treatment and prevention strategies for COVID-19. By identifying conserved regions of the virus's spike protein, the researchers aim to design therapies that remain effective even as the virus mutates. The approach combines expertise in mucosal immunology, structural biology, and virology to develop inhaled treatments that could provide rapid protection against COVID-19 and related coronaviruses. Patients may benefit from these innovative therapies that could enhance immunity and reduce the severity of infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk for COVID-19, including those with underlying health conditions or those in close contact with infected individuals.
Not a fit: Patients who are not at risk for COVID-19 or those who have already been vaccinated may not receive significant benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new inhaled treatments that provide broad protection against COVID-19 and its variants.
How similar studies have performed: Other research has shown promise in developing antibody therapies for COVID-19, suggesting that this approach could be effective.
Where this research is happening
Worcester, United States
- Univ of Massachusetts Med Sch Worcester — Worcester, United States (Active)
Researchers
- Principal investigator: Cavacini, Lisa a — Univ of Massachusetts Med Sch Worcester
- Study coordinator: Cavacini, Lisa a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.